Chelsea Landolin, RN, MS, NP
Associate Professor
Community Health Systems
School of Nursing

I am a nurse practitioner, health care administrator, nurse theorist, and Associate Clinical Professor in the UCSF School of Nursing. I teach students in the MS program, the Psychiatric/Mental Health Nurse Practitioner (PMHNP) Program, and directly train PMHNP students and psychiatric clinical pharmacy residents.

Show full bio (140 words) Hide full bio

I currently serve as Chair of the School of Nursing Faculty Practice Committee. I am former Chair of the Academic Senate Committee on Sustainability. I am elected Treasurer of the International Society for Evolution, Medicine, and Public Health.

In my faculty practice within UCSF Health Primary Care and the Office of Population Health, I lead a successful program that provides integrated behavioral health care to primary care patients. I have adapted certain techniques of cognitive behavior therapy (CBT) for efficiency in the primary care setting and train other providers in these strategies.

I also developed and implemented a novel training model to address the shortage of psychiatric providers through training future PMHNPs and clinical pharmacists to collaborate in the care of psychiatric patients (see website below).

Please feel free to contact me with any questions or inquiries.

Awards

Show all (1) Hide

• ISPN Psychiatric Mental Health Advocacy Award, International Society of Psychiatric-Mental Health Nurses, 2020

Interests

Show all (3) Hide

• Nursing Theory
• Cognitive Behavior Therapy
• Nurse Practitioner Practice

Websites

Show all (4) Hide

• Executive Summary: UCSF Dyad Training Program for Collaboration in Advanced Practice Psychiatric Nursing and Clinical Pharmacy (nexusipe.org)
• Novel IPE Partnership Aims to Expand Access to Mental Health Care (scienceofcaring.ucsf.edu)
• Faculty Practice (ucsfhealth.org)
• International Society for Evolution, Medicine, and Public Health (isemph.org)

Publications (2)

Top publication keywords:
Antidepressive AgentsDepressionTreatment OutcomeMemantineDrug Therapy, CombinationDrug MonitoringAdultDrug SynergismFemaleReceptors, N-Methyl-D-AspartatePsychiatric Status Rating ScalesExcitatory Amino Acid AgonistsDepressive Disorder, MajorDiagnostic and Statistical Manual of Mental DisordersMale

• Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial.
  The Journal of clinical psychiatry 2013 Smith EG, Deligiannidis KM, Ulbricht CM, Landolin CS, Patel JK, Rothschild AJ
• Psychosis in major depression. In: Fujii D, Ahmed I, eds. The Spectrum of Psychotic Disorders: Neurobiology, Etiology and Pathogenesis
  Psychosis in major depression. In: Fujii D, Ahmed I, eds. The Spectrum of Psychotic Disorders: Neurobiology, Etiology and Pathogenesis. 2007 Smith EG, Burke PR, Grogan JE, Fratoni SE, Wogsland CS, Rothschild AJ.